174
A.R.D. Stebbing . R.I. Willows
a Log EROD (Female dab liver)
o
b
Log CN-ECOD (Female dab liver)
c
Log AChE (Dab liver)
4.0
-1
o
t
3.6
- 1
t
- 2
-2
3.2
2 3 4 5 6 7 8 9
2 3 4 5 6 7 8 9
4 5 6 7 8 9
d Anaphase aberrations (%)
e Log lysosomal stability
Epidermal Papilioma (%)
20 (Female dab (20-24 em))
80
(Dab embryos)
2.0
(Female dab liver)
\
70
I j j j j j
1.5
60
1.0
t
50
40
0.5
2 3 4 5 6 7 8 9
2 3 4
9
90
80
.<:
~
g, 70
(;
;0
.~ 60 .........
;;:
~ 50 ......... ...... .. ........... .. ..... .. ........ .
~
40
30L---~------~------r_----_,r_~
Station 0
Station 2
Station 4
Station 6
S6"
Malformation rate ('MI)
DAB. stages la-II
• ~.
SS'
•
e
• • ,. -.
54'
~
•
BI~
3"
4'
S·
6'
7'
8'
9'
t
t t t t
j j llll
15
10
6 7 8 9
2 3 4 5 6 7 8 9
h
l00r_-----------------------------,
95
90
g 85
8
'080
1:: <11
~ 75
70
65
60L---~------r_------r_----_,r_~
Station 0
Station 2
Station 4
Station 6
56
•
••••
Malformation rate"')
DAB. stages la-II
9
• •
•
55'
e
• •
7
• ••
•
6
•••
54'
l· e2~ I
S
•
__ :t..._
•
e l~
.... r
...-..~'
3'
4'
S'
6'
7'
8'
9'